Hostname: page-component-77c89778f8-sh8wx Total loading time: 0 Render date: 2024-07-17T05:59:12.685Z Has data issue: false hasContentIssue false

Risk reduction studies in schizophrenia

Published online by Cambridge University Press:  02 January 2018

S. K. Chaturvedi*
Affiliation:
North Staffordshire Combined Healthcare NHS Trust, Greenfield Centre, Furlong Road, Tunstall, Stoke-on-Trent ST6 5UD, UK. E-mail: skchatur@hotmail.com
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © 2005 The Royal College of Psychiatrists 

Niemi et al's (Reference Niemi, Suvisaari and Haukka2004) report does not truly address the implications of their findings. Their clinical implications (p. 16) summarise their results, but one fails to draw clinical sense of it or be in a position to use the information in clinical practice. One could be cynical about their findings; the offspring of mothers with schizophrenia or psychotic disorders are expected to be at increased risk, which could vary across studies owing to a multitude of factors, so the findings of the study are no surprise. The increased risk could be genetic, psychosocial or both.

The clinical implications of high-risk studies ought to help identify those at high risk and prevent health problems in them. A number of studies on risk reduction strategies have been reported for common medical problems, including diabetes (Parillo & Ricardi, 2004), cardiac disorders (Reference FerdinandFerdinand, 2004) and atherosclerotic vascular disease (Reference Heckam and AnandHeckam & Anand, 2003) and even complex multi-factorial disorders such as hypertension (Reference Sheridan, Pignone and DonahueSheridan et al, 2003), to name a few. Although little can be done about the genetic component of the risk, the psychosocial and environmental effects can definitely be minimised. Multiple appropriate lifestyle alterations and stress protective strategies may be relevant. Furthermore, one expects that over time, the more recent studies should report relatively lower rates of elevated risk compared with those done decades earlier. Incidentally, Niemi et al found an incidence of 6.7%, lower than the 16.2% found in a study reported in 1993, and 13.1% in one reported in 1995, showing a gradually decreasing receding trend. Niemi et al attribute these differences to methodological factors, but one wonders whether the reduction can be attributed to preventive measures being implemented with those at high risk, advertently or inadvertently.

What is the point of knowing that people are at increased risk of developing a disorder if nothing can be done with this knowledge?

Footnotes

EDITED BY KHALIDA ISMAIL

References

Ferdinand, K. C. (2004) The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials. Clinical Cardiology, 27 (suppl. 3), 1215.Google Scholar
Heckam, D. G. & Anand, S. S. (2003) Emerging risk factors for atherosclerotic vascular disease: a critical review of evidence. JAMA, 290, 932940.Google Scholar
Niemi, L. I., Suvisaari, J. M., Haukka, J. K., et al (2004) Cumulative incidence of mental disorders among offspring of mothers with psychotic disorder. Results from the Helsinki High-Risk Study. British journal of Psychiatry, 185, 1117.CrossRefGoogle ScholarPubMed
Parillo, M. & Riccardi, G. (2004) Diet composition and the risk of type-2 diabetes: epidemiological and clinical evidence. British journal of Nutrition, 92, 719.Google Scholar
Sheridan, S., Pignone, M. & Donahue, K. (2003) Screening for high blood pressure: a review of the evidence for the US Preventive Services Task Force. American journal of Preventive Medicine, 25, 151158.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.